
- Telehealth Visits

Sanford C. Newmark, MD
Integrative MedicineMedical Director, Osher Center for Integrative Health- Telehealth Visits



Sanford C. Newmark, MD
Integrative MedicineMedical Director, Osher Center for Integrative Health- Telehealth Visits
On this page
About me
Dr. Sanford Newmark is a pediatrician who cares for children with autism, attention-deficit/hyperactivity disorder (ADHD) and other developmental or chronic childhood conditions. His practice combines conventional medical treatments with nutrition therapies, behavior management and other complementary modalities. He is medical director of the UCSF Osher Center for Integrative Health and head of its neurodevelopmental pediatrics program.
Newmark earned his medical degree and completed a residency in pediatrics at the University of Arizona College of Medicine – Tucson. After working as a general pediatrician in Tucson for 12 years, he completed a fellowship in integrative medicine at the University of Arizona's Andrew Weil Center for Integrative Medicine.
Newmark is a member of the American Academy of Pediatrics.
Education
Board Certification
- Pediatrics, American Board of Pediatrics
Fellowship
- Integrative Medicine, University of Arizona Hlth Sci Ctr - Pediatrics
Residency
- University of Arizona Health Science-Banner Health
- Pediatrics, University of Arizona Hlth Sci Ctr - Pediatrics
Internship
- Pediatrics, University of Arizona Hlth Sci Ctr - Pediatrics
School
- MD, University of Arizona College of Medicine
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Integrative Medicine
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
